Alcoa agreed on June 30, 2026, to acquire South32's bauxite, alumina, and aluminum operations for $3.1 billion in cash plus…
Read More

Alcoa agreed on June 30, 2026, to acquire South32's bauxite, alumina, and aluminum operations for $3.1 billion in cash plus…
Read More
GSK announced Tuesday it will acquire Nuvalent, a cancer drug developer, for $10.6 billion. CEO Luke Miels, six months into…
Read More